An antimicrobial wound dressing that includes anesthetic lidocaine for pain management from Middleton’s Imbed Biosciences has been federally approved for sale, the Wisconsin State Journal reports. The dressing helps manage wounds including venous stasis ulcers, pressure sores, ischemic ulcers, partial thickness burns, donor site wounds, surgical wounds, post-surgical incisions, abrasions, and lacerations.
The product will launch in May. Its approval follows the FDA’s approval in 2016 of the company’s earlier product, Microlyte Ag, a medical device.
